Archive for 'Minimally invasive prostate cancer treatment'
While the use of Viagra (sildenafil) has become fairly mainstream, most men would certainly opt for the sexual potency to go without it. Whether man-to-man or patient-to-doctor…
This week Medicare announced that it will continue to pay in full for the use of Provenge in treating prostate cancer when used in accordance with label indications. Provenge is a relatively new, FDA-approved drug used for patients with advanced prostate cancer. Unlike immunotherapy or chemotherapy, it uses a patient’s own cells to fight the […]
I recently returned from Israel after having attended the second annual Rambam Summit at Rambam Hospital in Haifa. This summit was attended by esteemed physicians, scientists, economists, academics and politicians from Israel and abroad. While the main theme of this years’ two-day summit was pediatric care and Rambam’s plans for the construction of the Ruth […]
Dr. Samadi is of the very few urologic surgeons in the United States trained in oncology, open, laparoscopic, and robotic surgery. To date, he has performed over 3,300 successful robotic laparoscopic prostate surgeries. And when dealing with a sensitive procedure such as prostate surgery, which can affect sexual health and incontinence, experience speaks volumes. Patients […]